Innovative Therapeutic Strategies for Cystic Fibrosis: Moving Forward to CRISPR Technique
One of the most revolutionary technologies in recent years in the field of molecular biology is CRISPR-Cas9. CRISPR technology is a promising tool for gene editing that provides researchers the opportunity to easily alter DNA sequences and modify gene function. Its many potential applications includ...
Main Authors: | Michele Marangi, Giuseppa Pistritto |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2018-04-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | http://journal.frontiersin.org/article/10.3389/fphar.2018.00396/full |
Similar Items
-
Cost-effectiveness analysis of lumacaftor and ivacaftor combination for the treatment of patients with cystic fibrosis in the United States
by: Dolly Sharma, et al.
Published: (2018-09-01) -
Drug-induced dyspnea versus cystic fibrosis exacerbation: a diagnostic dilemma
by: Walayat S, et al.
Published: (2017-07-01) -
Gene therapy-emulating small molecule treatments in cystic fibrosis airway epithelial cells and patients
by: Q. Yang, et al.
Published: (2019-12-01) -
Anti-Inflammatory Influences of Cystic Fibrosis Transmembrane Conductance Regulator Drugs on Lung Inflammation in Cystic Fibrosis
by: Kiera H. Harwood, et al.
Published: (2021-07-01) -
Computed Tomographic Changes in Patients with Cystic Fibrosis Treated by Combination Therapy with Lumacaftor and Ivacaftor
by: François Arnaud, et al.
Published: (2021-05-01)